Healthcare / Medical DistributionThailand
$1.25
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 17%
FCF escenarios
weak_data · normalized FCF $-97.2M · quality 39.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
36/100
D
Piotroski
2/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$260M
P/E
5.2x
↓EV/EBITDA
6.5x
↓ROE
1.5%
↑Gross Margin
34.5%
↓Debt/Equity
0.46
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-23.2%
FCF CAGR
—
FCF margin
-16.9%
FCF / Net income
-14.46x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $910.2M · net income $10.6M · FCF $-153.5M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $910.2M | $910.2M | $793.2M | $827.3M | $2.01B |
| Net Income | $10.6M | $10.6M | $41.7M | $79.2M | $296.7M |
| EBITDA | $83.0M | $83.0M | $101.9M | $127.8M | $406.2M |
| EPS | 0.05 | 0.05 | 0.20 | 0.35 | 1.32 |
| Gross Margin | 34.5% | 34.5% | 37.9% | 35.9% | 29.5% |
| Operating Margin | 4.1% | 4.1% | 8.4% | 11.7% | 18.6% |
| Net Margin | 1.2% | 1.2% | 5.3% | 9.6% | 14.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.46 | 0.46 | 0.36 | 0.05 | 0.05 |
| Current Ratio | 1.66 | 1.66 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-153.5M | $-153.5M | $-97.2M | $20.5M | $465.5M |
| Returns | |||||
| ROE | 1.5% | 1.5% | 5.5% | 8.8% | 28.9% |
| Valuation | |||||
| P/E | 5.21 | 5.21 | 29.25 | — | — |
| EV/EBITDA | 6.50 | 6.50 | 12.29 | — | — |
| P/B | 0.36 | 0.36 | 1.60 | — | — |
| Growth & Yield | |||||
| Revenue Growth | 14.8% | 14.8% | -4.1% | -58.8% | — |
| EPS Growth | -75.0% | -75.0% | -42.9% | -73.5% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
30.4%
EPS terminal req.
$0.11
Spread vs growth
-105.4%
5Y implied EPS CAGR
21.8%
EPS terminal req.
$0.13
Spread vs growth
-96.8%
10Y implied EPS CAGR
15.8%
EPS terminal req.
$0.22
Spread vs growth
-90.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+0.0%
Start / end P/E
29.2x → 117.0x
EPS bridge
0.20 → 0.05
Residual
-225.0%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.